1. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx). Issue 2 (16th October 2020) Authors: Awada, Gil; Ben Salama, Laila; De Cremer, Jennifer; Schwarze, Julia Katharina; Fischbuch, Lydia; Seynaeve, Laura; Du Four, Stephanie; Vanbinst, Anne-Marie; Michotte, Alex; Everaert, Hendrik; Rogiers, Anne; Theuns, Peter; Duerinck, Johnny; Neyns, Bart Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗